Scout | Awards Supporting Cutting-Edge Technologies for Translational Science (ASCETTS) (R21 Clinical Trials Not Allowed)

This opportunity is no longer accepting applications.

grant

Awards Supporting Cutting-Edge Technologies for Translational Science (ASCETTS) (R21 Clinical Trials Not Allowed)

The National Center for Advancing Translational Sciences (NCATS) is offering grants through the ASCETTS program for developing innovative technologies to overcome challenges in translational science, especially in therapeutic development. This program focuses on early-stage, high-risk projects that have the potential for high rewards. The aim is to develop new or improved technologies to enhan…

Source

Agency: National Institutes of Health

Sub-agency: National Center for Advancing Translational Sciences

Program: SBIR

Award

Award Ceiling: $275,000

Funding Amount: $275,000

Dates

Opportunity Released: May 11, 2023

Open for Submission: May 11, 2023

Submission Deadline: June 19, 2025

Application Window Closes: June 19, 2025

Keywords

translational science

therapeutic development

innovative technologies

proof of concept

high-risk studies

exploratory technology development

technological efficiency

prototyping

therapeutic pipeline

bottleneck solutions

Supporting Links

Documents

Similar Opportunities

Unlock similar opportunities

Get the full picture on this opportunity

Create a free Scout account to unlock everything you need to decide fast and win the grant.

Instant Fit Analysis

Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
Deep agency & funder detail

Program context, sub-agency structure, and a full eligibility breakdown.
Source links & full documents

Jump straight to the solicitation and download every attachment.
Similar opportunities

Discover related funding matched to your work.

Get a Demo Sign Up

Already have an account? Sign In

Trusted by 500+ Happy Customers